Introduction
Acute acalculous cholecystitis (ACC) is most fre quently diagnosed in critically ill patients after trau ma, sepsis, extensive injury or surgery. Also well acknowledged are other disorders and clinical con ditions responsible for ACC, which include longterm fasting and/or parenteral feeding, resuscitation, circulatory failure, atherosclerosis, diabetes, solid malignant tumors, proliferative circulatory diseases as well as immunosuppressive disorders (AIDS) and myelosuppressive chemotherapy [1] [2] [3] [4] [5] [6] .
We present a case of a neutropenic patient with ACC following chemotherapy for acute lymphoblas tic leukemia.
Case report
A 23yearold patient with normal karyotype preB acute lymphoblastic leukemia and no mo lecular risk factors during the second complete re mission following the FLAM protocol chemotherapy (fludarabine phosphate, cytarabine, mitoxantrone hydrochloride) was subjected to the first consolida tion treatment according to the PALG ALL6 proto col (cyclophosphamide, cytarabine, pegaspargase). On day 2 of the first cycle she presented with fever (39°C), abdominal pain and diarrhea on the next day. Piperacillin/tazobactam, fluconazole and nifu roxazide were administered and after 24 h the tem perature returned to normal; after the next 6 days Laparoscopic cholecystectomy for acalculous cholecystitis in a neutropenic patient after chemotherapy for acute lymphoblastic leukemia the symptoms receded and her condition improved. On day 8 the symptoms recurred: fever (38°C), ab dominal pain and diarrhea. Additional tests demon strated a decrease in blood count parameters with granulocytopenia (WBC 0.1-0.0 G/l). Test results ex cluded bacteria in peripheral blood, neutropenic en terocolitis (abdominal ultrasound) as well as pseu domembranous enteritis (no Clostridium difficile in feces). Nevertheless, medical therapy was modi fied to include a broad spectrum antibacterial and antifungal regimen (meropenem, metronidazole, itraconazole) as well as granulocytecolony stim ulating factors (GCSF) (filgrastim). After 5 days of medical therapy the temperature returned to normal and abdominal pain subsided but nifuroxazide and GCSF were continued for the next 4 days because of agranulocytosis. Four asymptomatic days followed so the delayed second cycle of chemotherapy was introduced (on day 18 of the first chemotherapy cy cle). On the second day (the second chemotherapy cycle) the patient again presented with fever (39°C) and abdominal pain followed by diarrhea. Candida albicans was discovered in feces culture and the metronidazole medication administered since day 8 was then supplemented with ketoconazole and piperacillin/tazobactam as well as vancomycin and granulocytecolony stimulating factors when agran ulocytosis and Enterobacter cloacae were detected in peripheral blood. Improvement of the general con dition was observed as well as a marked reduction of abdominal pain. However, on day 9 the patient again presented with fever accompanied by vomit ing and acute pain in the right epigastrium. Abdom inal ultrasound demonstrated acalculous gallblad der with overdistention, wall thickening (up to 14 mm) and pericholecystic fluid (Photo 1). Acalculous cholecystitis was diagnosed and the medical ther apy continued (broad spectrum antibiotic regimen, GCSF, intravenous fluids, fasting). Nevertheless, the patient's condition deteriorated and on the next day symptoms of renal and liver failure were observed. The patient was qualified for lifesaving surgery. Laparoscopic cholecystectomy was performed after two units of platelet concentrate (PC) were trans fused and the platelet count increased to 43 G/l. Histopathological evidence demonstrated lympho cyte infiltration of the gallbladder mucous mem brane and hyperemia but no presence of neutrophil infiltrations, leukemia cells (TdT-, CD34-), bacteria or fungal cells. Bile culture showed no microorgan isms (bacteria or fungi). The patient was moved to the intensive care ward, where a broad spectrum antibiotic regimen, GCSF and erythrocyte con centrate (EC) and PC transfusions were continued. On postoperative day 2 the patient presented with fever (38°C) and lower values of peripheral blood pressure. Chest Xray demonstrated atelectaticin flammatory changes (parenchymatousinterstitial) in the lower lung lobes. Intensive respiratory reha bilitation was performed and the imipenem/cilasta tin sodium, vancomycin, metronidazole, teicoplanin, ketoconazole medication was supplemented with ciprofloxacin hydrochloride and cotrimoxazole. The therapy was effective; the patient's condition improved. During the next postoperative days the patient manifested no abdominal symptoms related to cholecystectomy, abdominal pain or diarrhea. On postoperative day 4 she was permitted to eat and well tolerated the light diet. On postoperative day 6 a marked improvement was noted in the picture of the peripheral blood. The GCSF was discontinued as well as antibiotic therapy 2 days later. The patient Photo 1. Ultrasound appearance of thickened wall gallbladder
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was transferred to the Department of Hematology and on postcholecystectomy day 17 she was dis charged from hospital in a good general condition.
Discussion
Chemotherapyinduced complications in pa tients with myeloproliferative disorders are relative ly frequent and directly lifethreatening to neutro penic patients. Aggressive chemotherapy is most frequently followed by neutropenic enteritis, while acute acalculous cholecystitis is rare and reported in 0.4% of patients. In approximately 30% of them the prognosis is poor due to the severe overall condition induced by the underlying disease [1-3, 7, 8] . The ACC occurs with no deposits and is a local necrot icinflammatory process mostly ongoing in critically ill patients due to severe systemic disorders relat ed to e.g. trauma, circulatory insufficiency, systemic sepsis or extensive injury [1] [2] [3] [4] . Although as yet ACC pathogenesis is not well recognized, gallbladder wall hypoxia is considered as one of its major causative factors. In the course of trauma, systemic sepsis or inflammatory response vasoactive substances (re ninangiotensin) as well as proinflammatory medi ators and/or medications (catecholamines) are re leased into the blood and this induces vasospasms (small arteries in particular) that bring on hypoxia and ischemia reperfusion syndrome. Other etiolog ical factors that are most likely responsible for de creased perfusion of the gallbladder wall and acalcu lous inflammation include feverrelated dehydration and impairment of gallbladder motor functions that induce cholestasis and gallbladder overdistention [2] [3] [4] 8] . Although many studies point to hypoxia/ oxygen deficiency as the major factor in gallbladder wall injury and ACC (regardless of the underlying cause), there are also other acknowledged patho mechanisms of impaired gallbladder integrity. Mu cosal epithelium injury may be directly related to bile stasis or cytotoxic medication (chemotherapy) or indirectly to neutropenia or immunosuppression [1, 3, 6, 7] . Bacteria in gallbladder are isolated only in about 24% of neutropenic patients with ACC. In the remaining cases the cultures are usually sterile. This observation is not fully explicable but most authors are of the opinion that pathogenesis of infection in ACC is secondary to hypoxia and even in sepsis induced by various types of pathogens gallbladder necrosis becomes the secondary focus of infection [1] [2] [3] [4] . In the present case we observed several fac tors that were most likely responsible for ACC. These included chemotherapy, neutropenia, fasting, fever, diarrhea and bacteremia. Neutropenic enterocolitis was suspected when the patient presented chemo therapyinduced neutropenia followed by fever and abdominal pain. The diagnosis was not confirmed but a broad spectrum antibiotic regimen and GCSF were administered as classic management of fe verish neutropenic patients. Complications also oc curred after the second cycle of chemotherapy and their course was similar to that of day 9, when the patient reported a different type of abdominal pain and only in the right epigastrium. Medical interview and clinical observations led to the diagnosis of cho lecystitis, later confirmed by abdominal ultrasound [1-7, 9, 10] . Early diagnosis of cholecystitis is not easy in critically ill and often unconscious patients undergoing intensive treatment (respiratory therapy, sedation). Such diagnosis may be further prolonged until acute abdominal pain is reported and/or the patient's general condition worsens as a conse quence of gallbladder necrosis or perforation [2] [3] [4] [5] . The modalities of choice for ACC diagnosis are ultra sound and computed tomography, which reveal the characteristic features of cholecystitis. The most re liable ACCspecific symptom (90-98% -ultrasound) is gallbladder wall thickened to > 3-4 mm as well as lack of deposits or biliary sludge. The diagnosis is also confirmed by the presence of pericholecystic fluid, gas in the gallbladder wall or intramural ede ma which presents as a "halo" effect. Despite the high sensitivity and specificity of ultrasound it may provide false positive ACC diagnosis. In cases of "in visible" sludge or shadowless deposits as well as in cases of hypoalbuminemia and ascites there may occur "noninflammatory" thickening and edema of the gall bladder wall [2, 3, 5] . The firstchoice sur gical procedures in the management of critically ill patients with ACC and considered the least invasive are cholecystostomy (performed under local anes thesia and ultrasound guidance) and laparoscopic cholecystectomy (LCh). The cholecystostomy proce dure is effective for about 80% of patients and the removal of the drainage after 3 weeks usually com pletes ACC treatment. If no improvement is reported, emergency removal of the gallbladder is indicated. Many authors therefore share the opinion that cho lecystectomy and laparoscopic cholecystectomy in particular should be performed immediately after ACC diagnosis -even in critically ill patients. Cho lecystectomy eliminates the potential infection foci, and reduces the risk of ongoing infection (sepsis) and further complications (multiorgan failure). The LCh is recommended for patients with no absolute contraindications for surgery, especially those with low risk of conversion to open surgery. In cases of severe/acute inflammation such as gall bladder ne crosis, the risk of conversion to open surgery is the highest, and therefore open cholecystectomy (OCh) seems to be the best option. In the present case the ultrasound image was suggestive of gall bladder necrosis, and although edema was diagnosed intra operatively, no technical complications followed and the organ was removed laparoscopically. This con firms the positive opinion about the effectiveness of cholecystectomy in ACC treatment [11] [12] [13] . There are authors who do not acknowledge the greater ad vantage of laparoscopy in this group of patients and report similar incidence rates for complications and mortality for both the cholecystectomy techniques (LCh and OCh). In the case of laparoscopic cholecys tectomy, however, not only is trauma reduced but the risk of infection is lower than for the open proce dure because the incision wounds and the operation field are smaller. This is especially important in the case of immunesuppressed neutropenic patients, for whom any kind of infection is a threat [1] [2] [3] [11] [12] [13] [14] [15] [16] . Chemotherapyinduced neutropenia in patients subjected to myelosuppressive therapy is a singular ly predisposing factor for lifethreatening infections, abdominal infections included. In these cases the primary treatment of choice is a broad spectrum an tibiotic regimen, GCSF, fasting, intravenous hydra tion and/or total parenteral nutrition as well as close observation of the patient's clinical condition for signs of further complications. Such therapy is often effective and sufficient for neutropenic enterocolitis, while surgery (resection) is reserved for treatment of complications (such as transmural necrosis or intestine perforation). In neutropenic patients with ACC medical therapy should however be quickly sup plemented by a surgical procedure adjusted to the patient's general condition. In the case of coexis tent choledocholithiasis and cholestasis in particular preoperative endoscopic removal of deposits is first recommended, followed by a selected minimally in vasive cholecystectomy technique. Other minimally invasive techniques such as hybrid NOTES and lapa roscopy or modifications of the classic 3-4 port ac cess to the SILS port seem to have less impact on the postoperative course. The choice of surgical tech nique depends mainly on the patient's clinical condi tion, while other factors (aesthetic and cosmetic) are secondary. Laparoscopic cholecystectomy is a lesser burden to the patient and ensures the removal of the affected organ. It should therefore be the pre ferred technique rather than cholecystostomy. The procedure improves the patient's general condition and minimizes the risk of further complications such as multiorgan failure [1-3, 5-7, 10-16] .
Conclusions
In neutropenic patients with ACC intensive med ical therapy (a broad spectrum antibiotic regimen) should immediately be supported by a surgical pro cedure adjusted to the patient's general condition. After removal of the affected gallbladder, which is a potential focus of infection, the ACC symptoms subside and the patient's condition is stabilized. Minimally invasive techniques are preferred in the surgical management of ACC patients as they mini mize surgeryrelated trauma, infection risk and for mation of further infection foci.
